Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial.

Published in: Biomolecules (2021)

Bile duct cancer (BDC) has been identified as a highly aggressive cancer arising from epithelial cells of the bile duct, including intrahepatic, perihilar, and extrahepatic [...].

Keyphrases

papillary thyroid
clinical trial
squamous cell
lymph node metastasis
randomized controlled trial
squamous cell carcinoma
radiation therapy
childhood cancer
open label
cancer therapy
double blind